Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management.

MLA

Newbold, K. L., et al. “Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management.” Clinical Oncology (Royal College of Radiologists (Great Britain)), vol. 29, no. 5, May 2017, pp. 307–09. EBSCOhost, https://doi.org/10.1016/j.clon.2016.12.008.

APA

Newbold, K. L., Flux, G., & Wadsley, J. (2017). Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management. Clinical Oncology (Royal College of Radiologists (Great Britain)), 29(5), 307–309. https://doi.org/10.1016/j.clon.2016.12.008

Chicago

Newbold, K L, G Flux, and J Wadsley. 2017. “Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management.” Clinical Oncology (Royal College of Radiologists (Great Britain)) 29 (5): 307–9. doi:10.1016/j.clon.2016.12.008.